Introduction End-stage liver disease (ESLD) is a major cause of morbidity and mortality. However, little is known about symptom prevalence among this population. Aim(s) To systematically review the prevalence of symptoms and how they are measured in patients with ESLD Method(s) Eight electronic ...
Liver diseases are highly prevalent. While death rates of most other diseases, such as heart disease and cancer, have decreased, standardized mortality rates of liver diseases have increased up to 400% in the last decades. Cirrhosis is the endstage of patients who have chronic progressive liver ...
Traditionally, Maddrey discriminant function (DF) score and Child-Turcott-Pugh (CTP) score have been used for stratifying the prognosis of alcoholic hepatitis. Recently, the model for end-stage liver disease (MELD) score has been applied to alcoholic hepatitis and some investigators consider MELD ...
alcoholic cirrhosisliver failureliver transplantationdenial of treatmentsurvival statisticsLiver transplantation is now a routine procedure and is seen as a valid treatment option for end-stage liver disease. Alcoholism has been regarded as a relative or absolute contraindication to liver transplantation in...
11.Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.BMC Gastroenterol. 2002;2:2.[PubMed][DOI][Cited in This Article:1][Cited by in Crossref: 123][Cited by inRCA: 114][Article Influence: ...
Pharmacotherapy for Nonalcoholic Fatty Liver Disease Lifestyle modifications and optimization of the management of cardiometabolic comorbidities are currently the mainstay of treatment for patients with nonal... S Gawrieh,N Chalasani - 《Seminars in Liver Disease》 被引量: 20发表: 2015年 Endstage ...
Indications for liver transplantation. Candidates for OLT must have irreversible acute or chronic end stage liver disease (table 41b.1). Virus or alcohol-induced liver cirrhosis constitute the m... JG O'Leary,R Lepe,GL Davis - Springer US 被引量: 191发表: 2002年 Nonalcoholic fatty liver di...
Reduced Uptake of FDOPA PET in End-stage Liver Disease With Elevated Manganese Levels Susan R. Criswell, MD; Joel S. Perlmutter, MD; Jeffrey S. Crippin, MD; et al Tom O. Videen, PhD; Stephen M. Moerlein, PhD; Hubert P. Flores, MS; Angela M. Birke, BA; Brad A. Racette, MD ...
examples ofnatural compoundswhich act on RAGE, in order to reduce the negative effects resulting from their activation [189–193]. This is the case oftrans-resveratrol (58,Fig. S1) andglycyrrhizic acid(123,Fig. S1) which reduce RAGE expression, thus ameliorating the disease-asso...
Evidence-Based Decision for Pharmacological Management of Alcoholic Liver Disease and Alcohol Dependence Alcoholism is a major public health problem, and alcoholic liver disease (ALD) with its complications is still one of the most frequent causes of death in the Western countries. The feasibility of...